Hyper Interdisciplinary Conference in Kansai Forum 2020
- Conference Theme
- Circle of Knowledge for a Sustainable Society - Medical Care and Living Environment in the After Corona
- Day & Time
- Sunday, June 21, 2020 9:00-17:30
- Place
- Kobe International Conference CenterAccess
Many researchers and companies have been working toward the realization of such a sustainable society, where the natural environment is properly preserved and future generations can also utilize resources, while the needs that arise in our lives today are also met. However, the global spread of the new type of coronavirus has prompted further updates to the sustainable society that has been touted. As people's lifestyles change dramatically, what new normalcy will we attain?
The "Circle of Knowledge" in the theme of this forum is the fused knowledge that is created when passionate people join hands. In this forum, academia, large corporations, venture companies, town factories, and junior and senior high school students will gather to discuss issues that transcend age, field, and industry, with the hope that participants will work together to create new knowledge that will form the new normal in after-corona.
The Japan Society for Hyperdifferentiation Kansai Forum 2020 has ended.
[Participant
Academia, venture companies, large companies, town factories, local governments, junior high and high school students
Project Keywords.
Medical, Health, Environment, Living Environment, Agriculture, Forestry, Fisheries, Education, With/After Corona etc.
Register your poster abstract
Target: Researchers, junior high and high school students, school teachers, etc.
*Registration is now closed. Thank you for registering.
Booth Registration
Target: Venture businesses and small factories
*Registration is now closed. Thank you for registering.
Participation fee for auditing
Corporations, foundations, incorporated associations: ¥56,980 (tax included)
Booth exhibitors (venture companies, local factories): Free of charge
Non-incorporated entities (researchers, producers, local governments, teachers, students, and pupils): Free of charge
Partner Companies
Rohto Pharmaceuticals, Kansai Electric Power Company, Duskin, Focus Systems, Bayer Yakuhin, Taisho Pharmaceutical, Sysmex, Inoka, etc.
▼ 9:00-9:10 Hall A
Opening Ceremony
<Opening Remarks
Vice President CTO and Representative Director, Liverness, Inc.
Jyo Inoue
D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing his doctoral studies, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and an assistant professor at the Graduate School of Medicine, Kyoto University, before being appointed and concurrently serving as a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015, and as a professor of advanced pharmacy at the Faculty of Pharmaceutical Sciences, Kumamoto University and a visiting professor at Keio University's Faculty of Pharmaceutical Sciences in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.
▼ 9:10-9:30 Hall A
Keynote Speech ①.
Transforming Medicine Beyond Global Challenges: Pharmaceutical Companies' Initiatives
<Speakers
Bayer Yakuhin K.K.
Open Innovation Center
center director
Mr. Shunichi Takahashi
D. in Chemistry from the Graduate School of Science and Engineering, Aoyama Gakuin University. After joining Mitsui Pharmaceutical Industries (at that time), he was transferred to the Cardiovascular Research Division of the U.S. subsidiary Barlex Biosciences at Nihon Searing after the business integration, where he worked in the Cardiovascular Research Department and Immunology Research Department. After the business integration with Bayer Yakuhin, he worked as a senior researcher in the Regenerative Medicine Research Division at Kobe Research Center, Manager of the Cardiovascular Area of Project Management in the Development Division, and Director of the Medical Affairs Primary Care Department before becoming the Director of the Open Innovation Center in June 2014.
<Summary of Lecture
The spread of novel coronavirus infection (COVID-19) is having a major impact not only on medicine but also on our lives and society. In response to this global threat, industry, government, and academia must collaborate beyond conventional frameworks and processes to prevent the spread of infection and develop vaccines, therapeutics, and medical devices at an unprecedented speed. Mr. Shunichi Takahashi of Bayer Yakuhin K.K. will talk about what global pharmaceutical companies are doing to address this situation.
▼ 9:30-9:50 Hall A
Keynote Speech (2)
"We will realize a recycling society based solely on earthly resources."
<Speakers
Nihon Kankyo Sekkei Co.
chairman of board of directors
Mr. Yoshihiko Iwamoto
As a salesman in a textile trading company, he was in charge of uniform production and sales for many years. Feeling the challenge of creating products that only become a large amount of trash after being worn out, he established Nihon Kankyo Sekkei in January 2007. Aiming to create a society where resources are recycled, he not only develops recycling technologies, but also works with manufacturers, retailers, and other companies in various industries to unify the recycling process. Author of the book, "A Future without Disposal" will be born from this business (Diamond Inc.)
<Summary of Lecture
In recent years, the plastics problem has led to the promotion of recycling of resources more than ever before. It is necessary not only to develop and socially implement technologies that promote resource recycling to realize a sustainable society, but also to consider mechanisms to involve more people. Mr. Michihiko Iwamoto of Nihon Kankyo Sekkei, Inc., who is involved in resource recycling by involving many cooperating companies and consumers, will talk about how to involve society while basing technology development on the recycling of resources and the future society that will be realized as a result of such efforts.
▼ 10:00-11:00 Venue A
.
How to Attack Globalizing Infectious Diseases
Session Partner: Rohto Pharmaceutical Co.
With the simplification of transportation, the international movement of people and goods has become more active, and the definition of national borders has become blurred. It is no exaggeration to say that the history of mankind has been built on the battle against infectious diseases, but the COVID-19 outbreak has triggered a renewed awareness of the threat of infectious diseases that originate somewhere on the planet and spread globally in the blink of an eye. At the same time, research and development of medicines, treatment methods, and prevention methods have evolved, and we must respond not only in our own countries but also on a global scale. In this session, Rohto Pharmaceutical Co., Ltd. which globally develops regenerative medicine and prevention, MyCan Technologies, Inc. which develops research materials for drug discovery and vaccines using regenerative medicine, and GHIT Fund which invests in joint research and development of infectious diseases in developing countries in Japan and abroad will gather to discuss future countermeasures against infectious diseases. The event will discuss the future of infectious disease countermeasures.
<Speakers .
General Manager, Basic Research and Development Department, Rohto Pharmaceutical Co.
Tsuyoshi Ishii
After graduating from the Faculty of Pharmaceutical Sciences at Osaka University and completing the master's program at the same university, he joined Rohto Pharmaceutical in 1997 and was assigned to the Research and Development Division, where he was mainly engaged in basic research on skin aging and the development of functional cosmetics. In 2013, he joined the company's Regenerative Medicine Research and Planning Department, where he was involved in the development of regenerative medicine products. He has been in his current position at the company's Research Village Kyoto since 2017.
Leader, Biological Control Group, Basic Research and Development Department, Rohto Pharmaceutical Co.
Takahiro Kurose
In 2006, he completed the Master's course at the Graduate School of Pharmaceutical Sciences, Hokkaido University. In 2013, he was transferred to the Sanford-Burnham Research Center in the U.S., where he participated in a project to discover new drug seeds to inhibit retinal nerve cell death. In 2016, he assumed his current position and is engaged in project management of pharmacological research in ophthalmology drug development.
CEO and Representative Director, MyCan Technologies, Inc.
Kazuo Miyazaki
Graduated from Tokyo University of Science, Graduate School of Science. Specialized in synthetic organic chemistry and regenerative medicine. For about 20 years, he worked for a pharmaceutical company conducting exploratory research on small molecule compounds for vascular, renal, and central nervous system diseases, as well as small molecule compounds to complement regenerative medicine. His encounter with malaria, dengue fever, and other infectious diseases in India led him to establish MyCan Technologies, Inc. in 2016. Aiming to solve the challenges of special blood-borne infections using regenerative medicine technologies.
GHIT Fund (Global Health Technology Fund)
Senior Director, Investment Strategy and Business Development
Kei Katsuno
He oversees the investment and development strategy of the GHIT Fund. After working as a physician at the National Center for Global Health and Medicine (formerly the National Center for Global Health and Medicine), he earned a Master of Public Health (MPH) degree from the Johns Hopkins University School of Public Health in the United States as a Fulbright Scholar. He then worked at the East West Center and the World Bank (as a health specialist) before assuming his current position in 2013. He graduated from the University of Tokyo School of Medicine with a Bachelor's degree in Medicine. He is board certified in both Japan and the United States (ECFMG). He is a Fellow of the U.S.-Japan Leadership Program.
Director, Knowledge Foundation Research Center, Liverness, Inc.
Hiroyuki Takahashi
D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. In addition, he continues to organize the "Super Interdisciplinary Society," a place to generate new knowledge and seeds for research and development by combining individual knowledge, technology, and passion for problem solving without being bound by the framework of academia.
▼ 10:00-11:00 Venue B
.
technology splash
Splash means "to jump or splash (water, etc.), to fall with a zap. In this session, researchers who are presenters will share the most passionate aspects of their research with the participants, transcending the boundaries of their fields and affiliations. The participants (audience), on the other hand, are plunged into the world of different fields, bathed in the knowledge and enthusiasm of the researchers who appear one after the other. In a series of short presentations in very different fields, the enthusiasm of the presenters and the enthusiasm of the participants collide, and new research ideas and friends are born as if by splashing. That is what "Technology Splash" is all about.
. D., University of the Ryukyus, 2016. D. in Science. D. in Science from the University of the Ryukyus in 2016. He is also involved in the operation of the Regional Tech Planter, which aims to create an ecosystem for industry creation by discovering and fostering local researchers and ventures, and working with government, financial institutions, and local companies. <Researchers who presented <Presentation Venture
Regional Development Business Department, Osaka Head Office, Liverness Co.
Sho Nakaejima
No.
(in one's) possession
identity
theme
Poster No.
1
The University of Tokushima
Satoshi Taniguchi
Considerations on how to search for diabetic apps
P-2
2
The University of Tokyo
Yuhei Shimada
Legal Issues for Health Tech Products - Online Medical Treatment, Medical AI, Wearable Devices, and Personal Information
P-3
3
Chukyo University
Jun Kaneko
What we have learned from "barefoot" research
P-5
4
Osaka University Graduate School
Anna Shimafuji
Diversity - How to develop innovators
P-9
5
Osaka University Graduate School
Shohki Kishida
Quality control mechanism of the cell's energy factory "mitochondria".
P-13
6
Okayama Prefectural University
Masato Kanazaki
Repair and bonding of carbon fiber reinforced thermoplastics (CFRTP) utilizing resin welding
P-15
No.
Company Name
Theme Overview
Booth No.
7
Cuol Corporation
We have the technology to create humanized mice, mice with human cells and tissues. By creating humanized mice for various diseases, we are working to support the development of novel therapies.
B-3
8
AMI Corporation
We are developing a "super stethoscope," a stethoscope that assists in the diagnosis of cardiac diseases. We are also implementing "Cloud Kenshin," a core technology of "remote auscultation video chat system" that realizes high quality telemedicine We will realize rapid medical innovation through AI x telemedicine.
B-4
9
Teclico Corporation
Provide state-of-the-art rehabilitation to realize a society that extends healthy life expectancy. MR/VR rehabilitation that will also lead to solutions to medical/welfare staffing shortages. We aim to provide fun rehabilitation without forgetting entertainment.
B-7
10
Kihata Keiki Seisakusho Co.
A specialized manufacturer of pressure gauges. Also manufactures and sells respiratory muscle strength measuring devices for medical equipment. With the support of the Kobe Medical Industry Development Organization for healthcare equipment development, the company plans to conduct joint research with Hyogo University of Medical Science on standard values of respiratory muscle strength for modern Japanese people.
B-8
11
Scrier Corporation
We provide apps, IOMT, medical devices with visible treatment effects, and rehabilitation devices that benefit both dentists and patients by reducing the burden of visits to the dentist (contact opportunities) and making medical information visible. / We enable stable data collection in the oral region, sleep training, not sleep learning.
B-9
12
Galderia Corporation
We will utilize the high survival ability of the sulfuric acidic hot spring red alga Galderia under high temperature and strong acidity and its ability to selectively adsorb precious metals to achieve culture and CO2 fixation under extreme conditions, while realizing a precious metal recycling flow with a low environmental impact.
B-10
13
Parity Innovations, Inc.
By applying the airborne image display technology developed by our company and realizing non-contact UI such as airborne switches and airborne touch displays with excellent cleanliness and antifouling properties, we will contribute to the improvement of public health in the age of with corona, namely, countermeasures against infectious diseases.
B-11
14
Sumitomo Heavy Industries, Ltd.
At Sumitomo Heavy Industries, our goal is to realize a society in which people can work with greater peace of mind. We are taking on the challenge of automating the manufacturing of large structures, which until now required manual labor, through the use of our unique mobile robot technology.
B-12
▼ 11:00-12:00 Hall A
.
Creating a New Era of Medical Care
~Considering the structure of venture support~.
Session Partner: Bayer Yakuhin K.K.
In the past, when looking at medical applications of research, there were many hurdles to overcome, such as clinical trials and regulatory approval, and the time required for social implementation was considered to be long, taking more than a decade. However, as a result of the crisis of globally spreading infectious diseases (COVID-19) and the united efforts of mankind, social implementation of research is progressing innovatively. We can learn from the current state of transition in medicine and glimpse a new era in which research can be promptly applied to medical care. In this session, we will discuss the new era of medicine from the angle of a new mechanism of venture support.
<Speakers
Bayer Yakuhin K.K.
Director, Open Innovation Center
Shunichi Takahashi
D. in Chemistry from the Graduate School of Science and Engineering, Aoyama Gakuin University. After joining Mitsui Pharmaceutical Industries (at that time), he was transferred to the Cardiovascular Research Division of the U.S. subsidiary Barlex Biosciences at Nihon Searing after the business integration, where he worked in the Cardiovascular Research Department and Immunology Research Department. After the business integration with Bayer Yakuhin, he worked as a senior researcher in the Regenerative Medicine Research Division at Kobe Research Center, Manager of the Cardiovascular Area of Project Management in the Development Division, and Director of the Medical Affairs Primary Care Department before becoming the Director of the Open Innovation Center in June 2014.
Representative Director and CEO, AMI, Inc.
Shinpei Ogawa
Born in Kumamoto City, Kumamoto Prefecture. Graduated from Kumamoto University Faculty of Medicine. Cardiologist.Established AMI Corporation in November 2015. Currently developing a "super stethoscope," a stethoscope that assists in the diagnosis of cardiac disease, and a tele-aural video chat system that realizes high-quality telemedicine; working toward the practical application of the telemedicine service "Cloud Kenshin" in Minamata City, Kumamoto Prefecture from 2018. Major awards include the 1st MedTech Grand Prix KOBE Grand Prize, C-startup Pitch Grand Prize, etc. In 2019, he was selected as Real Tech Venture of the Year in the Growth category.
Representative Director, Cuor Co.
Mr. Ryusho Kariya
Born in Kochi Prefecture. After qualifying as a pharmacist at Kobe Gakuin University Faculty of Pharmaceutical Sciences, he entered the Graduate School of Medical Education, Kumamoto University, where he engaged in research on AIDS-related malignant lymphoma and the development of novel hyper-immunodeficient mice. After obtaining his PhD (Medicine), he became a postdoctoral researcher and engaged in the development of novel anti-cancer drugs using the established super-immunodeficient mice. Currently, he serves as the president of Cuor Inc. which he established in 2018 and as a specially-appointed assistant professor at Kumamoto University's Joint Research Center for Human Retroviridae.
.
Vice President CTO and Representative Director, Liverness, Inc.
Jyo Inoue
D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing his doctoral studies, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and an assistant professor at the Graduate School of Medicine, Kyoto University, before being appointed and concurrently serving as a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015, and as a professor of advanced pharmacy at the Faculty of Pharmaceutical Sciences, Kumamoto University and a visiting professor at Keio University's Faculty of Pharmaceutical Sciences in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.
▼ 11:00-12:00 Hall B
.
How can you get involved in the workplace to change people and organizations?
Session Partner: Duskin Corporation
Today, as working styles diversify, the workplace environment, the place where people physically gather, is changing. Workplace cleaning is outsourced or left to robots, and teleworkers are increasingly telecommuting and not showing up at the office due to the Corona disaster. On the other hand, in Japan, many people have been familiar with the custom of cleaning together since elementary school, and the concept of 5S, which was born in the manufacturing industry, has not become old-fashioned. What kind of effect does it have on people and organizations when workers themselves are proactively involved in space creation, as in the case of cleaning, for example? Duskin Inc., a professional in the field of lifestyle and workplace environment improvement, will be joined by a company conducting empirical research on the workplace, as well as a researcher exploring the relationship between people and the greening of space.
<Speakers
Duskin Development Institute Co.
Mr. Masahiro Imanishi
Joined the company in 1983 and was assigned to the Equipment Engineering Department of the Production Division, which developed cleaning and processing equipment for mops and mats. In 1989, he was transferred to the Product Development Department of the mainstay Ai-no-Ten Business Division (now the Door-to-Door Sales Group). He was involved in product development of cleaning and sanitation products, mainly mops and mats. Later, after working in the head office division, he has been in charge of the Development Laboratory since 2008.
Frontier Consulting Inc.
Executive Officer, General Manager, Work Design R&D Dept.
Mr. Shinji Ineda
First-class architect. He joined Frontier Consulting from its inception to head the Design and Design Department, and from 2020 established the Work Design R&D Department to focus more on activity design. He is also responsible for the on-demand media "Worker's Resort," and researches offices and work styles in Japan and abroad.
D., Graduate School of Horticulture, Chiba University
/Representative, Lockak Kay LLC.
Mikiko Kamada
He completed his graduate studies at the Graduate School of Agriculture, Hokkaido University. His major was molecular plant breeding. After completing graduate school, he was involved in planning and development at a vegetable seed manufacturer, then studied indoor greenery and decoration and became an independent plant director. 2015, he founded Rokkakkei, LLC. and started the indoor greenery tool Tanicushion®️He has been engaged in product development and spatial greening projects, such as "The Greening of Space," and is currently a Ph. Currently, he is researching the "relationship between humans and plants" as a doctoral student at a graduate school, and is also involved in plant-based art exhibits.
.
Representative Director, President and COO, Liverness, Inc.
Shuichiro Takahashi
D. (Life Sciences), Graduate School of Frontier Sciences, The University of Tokyo. He has been involved in RIVANESS since its establishment. After completing his graduate studies, he continued his research activities as a faculty member at the University of Tokyo, while at the same time he established a research institute at RIVANESS and built the foundation of its research and development business. He devised the business model of "Liberness Research Grant," a unique research grant, and "L-RAD," a database of unutilized research ideas, and has initiated many open innovation projects involving industry, academia, and education.
▼ 13:00-14:00 Hall A
.
How will "new lifestyles" change health?
Session Partner: Taisho Pharmaceutical Co.
The rapid global spread of the new coronavirus infection has drastically changed people's lives in just a month or two. With a steady decrease in daily activity, eating habits, frequency of going out, and opportunities to talk to people, and changes in the way we maintain our health and communicate with others, are we aware of the changes in our own bodies? In this session, we will consider how we can make ourselves healthier both physically and mentally in this "new lifestyle" based on the skills of "knowing our own body condition" and expertise in health promotion.
<Speakers
President and Representative Director, Humanome Research Institute, Inc.
Jun Sese
D. in Science, Graduate School of Frontier Sciences, The University of Tokyo. D. in Science, Graduate School of Frontier Sciences, The University of Tokyo, and has served as Assistant Professor at the University of Tokyo, Associate Professor at Ochanomizu University, Associate Professor at Tokyo Institute of Technology, and Research Team Leader at the National Institute of Advanced Industrial Science and Technology (AIST). He specializes in the development of machine learning and mathematical statistics methods and large-scale data analysis in the life sciences. He won the KDD Cup 2001, a data mining contest of the American Society for Computing Machinery, and the Oxford Journals-JSBi Prize.
Representative Director, Exult Inc.
Kohei Shiomi
Born in Hokkaido, Japan. Graduated from Sapporo Medical University, Department of Physical Therapy. He is a certified physical therapist (metabolism) and a doctor of human care science. While engaged in clinical rehabilitation work at private hospitals and university hospitals, he also worked on preventive medicine research from the viewpoint of disease control at the Graduate School of Nephrology, University of Tsukuba. Recognizing the lack of social implementation of medical evidence, he established Exult, Inc. in 2019 to provide lifestyle guidance services based on functional tests and other data.
Associate Professor, Department of Bioscience and Biotechnology, School of Bioscience and Biotechnology, Tokyo Institute of Technology
Nobuhiro Hayashi
He holds a B.S. in Physics from the University of Tokyo and a Ph.D. from the Tokyo Institute of Technology, where he was a lecturer at Fujita Health University before assuming his current position in 2016. He is the representative of the Future Health Science Group of the Open Innovation Hub for Bioscience and Biotechnology, the representative of the Research Promotion Body for Futuristic and Sports Health Science at Tokyo Institute of Technology, and the director of the AI Proteomics Collaborative Research Center from 2019, promoting social implementation of AI proteomics through industry-government-academia collaboration. His areas of expertise are proteomics and molecular biology, and he holds 12 patents and over 100 international publications.
.
General Manager, Education Development Division, Riverness, Inc.
Satoshi Nishiyama
Completed graduate studies at the Graduate School of Life and Environmental Sciences, University of Tsukuba. D. in Science, conducting research on the development of gene therapy for mitochondrial diseases. He joined LIVERNESS Corporation as an intern during his second year of the master's program, and has been involved in the development of educational programs, planning joint research for industry-academia collaboration, and launching projects connecting researchers and ventures in different fields.
▼ 13:00-14:00 Venue B
.
Technology Splash Part 2
Splash means "to jump or splash (water, etc.), to fall with a zap. In this session, researchers who are presenters will share the most passionate aspects of their research with the participants, transcending the boundaries of their fields and affiliations. The participants (audience), on the other hand, are plunged into the world of different fields, bathed in the knowledge and enthusiasm of the researchers who appear one after the other. In a series of short presentations in very different fields, the enthusiasm of the presenters and the enthusiasm of the participants collide, and new research ideas and friends are born as if by splashing. That is what "Technology Splash" is all about.
. D., University of the Ryukyus, 2016. D. in Science. D. in Science from the University of the Ryukyus in 2016. He is also involved in the operation of the Regional Tech Planter, which aims to create an ecosystem for industry creation by discovering and fostering local researchers and ventures, and working with government, financial institutions, and local companies. <Researchers who presented <Presentation Venture
Regional Development Business Department, Osaka Head Office, Liverness Co.
Sho Nakaejima
No.
(in one's) possession
identity
theme
Poster No.
15
Kanagawa Prefectural Chuo Agricultural High School
Jilan Sadjawijit Manirat
Investigation of Hypertension Suppression Effect by Manuka Honey
P-17
16
Kansai University
Ken Ito
Investigation of the principle of antibacterial and bactericidal properties expressed by nanostructures and efforts toward their application
P-20
17
Momoyama Gakuin Junior High School
Naoki Sonoda
Effects of MMSE in Robot Therapy for Alzheimer's Disease and its Relationship to Cerebral Blood Flow
P-21
18
Momoyama Gakuin Junior High School
Naoki Sonoda
Hydrogen production from NaCl solution using cation exchange membrane method
P-22
19
Kobe University Graduate School
Junya Yamamoto
Development of a low-cost and highly efficient microbial production system for homo-γ-polyglutamic acid
P-24
20
Nagaoka University of Technology
Mika Takahi
Cardiomyocyte production method using human iPS cells from very low cell density
P-25
No.
Company Name
Theme Overview
Booth No.
21
MicroBiophactory, Inc.
We are developing technologies to produce chemicals using synthetic biology technology. Synthetic biology technology makes it possible to produce substances that could not be produced biologically before. By utilizing this technology, we will manufacture products that aim to eliminate the use of petroleum.
B-13
22
Kawano Lab
Based on the results of our research at Osaka University, we have applied particle analysis technology using magnetic and electric fields to quantify the wettability and dispersibility of particles, monitor the activity state of cells, and evaluate how they are incorporated into capsule materials.
B-15
23
Beyond Science
Ketobiotic powders can only be hydrolyzed by enzymes in gut bacteria. Ketone bodies are produced in the intestinal bacteria, and the new technology of prokaryotic cell activation transforms the microbiome and activates Tregs. We aim to put this technology to practical use in pet therapy diets.
B-16
24
Saidin Corporation
We aim to create innovative drug development and DDS technology using cyclodextrins, which are cyclic oligosaccharides.
B-22
25
Student Independent Research Initiative for the Promotion of Science (SINAPS)
By supporting independent research by students who have a high awareness of research, we are expanding the base of research activities. Research presentations: Our main activities are to hold Jamboree and support activities at Science Incarceration, a research presentation event sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT).
B-23
26
Nariko Seimitsu Co.
We specialize in metal cutting and processing of prototypes and palm-sized products, and can be entrusted with everything from CAD/CAM to lathe, MC, each processing, and surface treatment. We are a group of engineers who give shape to the ideas of developers and ventures.
B-24
27
MACHICOCO
MACHICOCO SCHOOL" is a school where you can learn about manufacturing onsite from engineers at a local factory. We are preparing a serious course for those who want to learn serious techniques, a petit technique course for those who want to experience and learn in a light way, and a factory experience tour. We are also preparing web-based courses and web-based experience tours for those who are too far away to come.
B-25
28
Sudix Biotech, Inc.
We have proprietary nano-biotechnological technology that utilizes sugar chains. We are using this technology to develop highly sensitive rapid genetic testing methods for viruses and therapeutic methods targeting cancer cells.
B-26
29
Agro Design Studio, Inc.
We are an agrochemical venture aiming to provide safe and secure food. We are engaged in research and development of molecularly targeted agrochemicals by utilizing our knowledge of structural biology.
B-28
▼ 14:00-15:00 Poster Room & Room A
＜Poster Session
We plan to have about 30 poster presentations by researchers and about 15 booths by venture companies and local factories. 1.5 to 2 m spacing between panels will be provided.
▼ 15:00-16:00 Hall A
<Session A4
Innovations in diagnostic technology are changing health care.
Session Partner: Sysmex Corporation
Testing and diagnosis play an increasingly important role in healthcare, such as early detection of diseases, personalized drug selection, and identification of unknown infectious diseases. At the same time, however, the realization of these goals requires a combination of various approaches, including knowledge and technologies from engineering and data science, in addition to new life science knowledge generated in academia. In this session, we will discuss how to incorporate the new science that is emerging one after another into social implementation in the form of diagnostics from the three perspectives of testing and diagnostic technologies, drug discovery professionals, and researchers in academia.
<Speakers
General Manager, Technology Strategy Division, Sysmex Corporation
Kenji Tsujimoto
D. from the Graduate School of Pharmaceutical Sciences, Kyoto University. After working for pharmaceutical companies and venture capital firms, he joined Sysmex Corporation in 2011. After being involved in business strategy formulation and M&A at the Business Strategy Division, he has served as the General Manager of the Technology Strategy Division from 2017 to the present. In addition to formulating technology strategies and promoting technology strategies utilizing open innovation, he also focuses on bridging from technology to business. (BRIH-K, BRIH-K), which supports the utilization of bioresources such as blood from patients.
Director, Liberace Capital Co.
Mr. Nobuo Hanai
In 2003, he established BioWa, Inc. in the U.S. to out-license the antibody-related technologies he had developed, and was appointed president and responsible for the company's operations. He was appointed Chairman of the Board in 2018 and Chairman of the Board in 2019, He retired in March 2020 and became a director of Liverness Capital in May of the same year.
Representative Director, Kawano Lab Inc.
Makoto Kawano
D. in Analytical Chemistry at Osaka University, he was selected for JST's A-STEP Young Entrepreneur Type program based on his research results, and after 3 years of research and development, he established Kawano Lab Inc. in 2015. He has developed a method for analyzing microparticles and cells based on the phenomenon of swimming by magnetic fields, and is concerned with single-particle analysis of wettability, dispersibility, crystallinity, surface coverage, cell viability and activity, and so on. Through joint research with universities and companies, we are also developing image analysis using deep-learning and various microspectroscopy methods.
Director, Knowledge Foundation Research Center, Liverness, Inc.
Hiroyuki Takahashi
D. from Yokohama City University in 2009. D. in Science, focusing on creating new research projects between industry and young researchers, including the launch of the "Liberace Research Fund" for young researchers under the age of 40. In addition, he continues to organize the "Super Interdisciplinary Society," a place to generate new knowledge and seeds for research and development by combining individual knowledge, technology, and passion for problem solving without being bound by the framework of academia.
▼ 15:00-16:00 Hall B
.
Creating an agri-tech demonstration field with a super interdisciplinary team - Hacking an orchard with IT x real tech
Session Partner: Focus Systems, Inc.
In recent years, research and development has been aggressively pursued by large corporations, venture companies, and researchers to realize agriculture using robots, IoT, and data. There have been an increasing number of efforts to develop demonstrations in actual agricultural fields in a wide range of fields, including paddy rice, open field vegetables, and facility cultivation. In this session, we will focus on fruit trees in particular, and discuss the next step forward with three researchers who have demonstrated sensing technologies essential for data utilization. Together, we will recruit colleagues who will work together to create the agriculture of the future.
<Speakers
President and Representative Director, Focus Systems, Inc.
Keiichi Mori
After graduating from the Faculty of Commerce at Keio University in 1989, he joined Deloitte Touche Tohmatsu & Co. After working at a tax accounting firm, he joined Focus Systems in 1998. He was appointed as Director in 2006 and Managing Director in 2009. In April 2011, he was appointed President and Representative Director.
President and Representative Director, Santo Farm Co.
Takayuki Sakota
After graduating from Kwansei Gakuin University, he took over his family's agrochemical dealership; in 2014, he founded the e-commerce business ePlus Inc. in 2014; in 2015, he established the agricultural business Santo Noen Inc. and in 2018 released "AgriShot," an artificial intelligence-based citrus pest diagnosis app.
Representative Director, Kisvin Science K.K.
Kazuhiro Nishioka
He developed a low-cost sap flow sensor that measures the flow rate of sap sucked up by plants from their roots, and founded a venture company at the University of Tokyo to promote its use in the agricultural scene. At the same time, he has served as an advisor to several agri-tech ventures. His love of wine led him to organize Team Kisvin, a viticulture research group, 14 years ago, while he was involved in winemaking in Yamanashi, Japan. This year, he will start winemaking in California, USA.
Representative Director, President and COO, Liverness, Inc.
Shuichiro Takahashi
D. (Life Sciences), Graduate School of Frontier Sciences, The University of Tokyo. He has been involved in RIVANESS since its establishment. After completing his graduate studies, he continued his research activities as a faculty member at the University of Tokyo, while at the same time he established a research institute at RIVANESS and built the foundation of its research and development business. He devised the business model of "Liberness Research Grant," a unique research grant, and "L-RAD," a database of unutilized research ideas, and has initiated many open innovation projects involving industry, academia, and education.
▼ 16:00-17:00 Hall A
.
Strategies to Prepare for the Second Wave of Infectious Diseases
Session Partner: Euglena Co.
In less than six months, novel coronavirus infections have dramatically changed the global landscape. The importance of promptly setting up testing and diagnostic systems for novel viral infections that could cause a global explosion of infection has been stressed, and a variety of testing methods have been announced around the world. Efforts are being made in various parts of the world to continue economic activities while making use of the information obtained from testing. In this session, we will invite players who aim to establish testing technologies to address this urgent issue and players who seek new ways of economic activities under such circumstances, and discuss ways to overcome novel coronavirus infections.
<Speakers
President and Representative Director, Euglena Co.
Mitsuru Izumo
After graduating from Komaba Toho Junior and Senior High School and the Faculty of Agriculture at the University of Tokyo, he joined the Bank of Tokyo-Mitsubishi in 2002, and in 2005 founded Euglena Co. In December of the same year, he succeeded in the world's first outdoor mass cultivation of the microalgae green lacewing (scientific name: euglena) for food use. He received the Young Global Leaders Award at the World Economic Forum (Davos Forum) and the Prime Minister's Award at the 1st Japan Venture Awards (2015). He is the author of "I decided to save the world with Green Beetle" (Shogakukan Shinsho). (Shogakukan Shinsho).
Senior Researcher, Custom-Made Medical Research, Inc.
Shuichiro Kashiwaba
Born in Kushiro City, Hokkaido. D. (Engineering) from the Graduate School of Engineering Science, Tokyo University of Science. After receiving his degree, he worked as a postdoctoral researcher at the Institute of Environmental Medicine, Nagoya University, and as an assistant professor at the Faculty of Fundamental Engineering, Tokyo University of Science before assuming his current position in April 2019. He brings his knowledge and experience in genetic engineering, cell biology, and other areas of expertise to immunology, and is developing technologies for the efficient production of pharmaceutical-grade antibodies.
.
Representative Director, Vice President CTO, Liverness, Inc.
Jyo Inoue
D. in Pharmaceutical Sciences from Tokyo University of Pharmacy and Life Sciences. He is a founding member of LIVERNESS. After completing his doctoral studies, he worked as an assistant professor and lecturer at the Faculty of Science, Kitasato University, and an assistant professor at the Graduate School of Medicine, Kyoto University, before being appointed and concurrently serving as a specially-appointed associate professor at the Institute for Advanced Biosciences, Keio University in 2015, and as a professor of advanced pharmacy at the Faculty of Pharmaceutical Sciences, Kumamoto University and a visiting professor at Keio University's Faculty of Pharmaceutical Sciences in 2018. While conducting research and development, he is a researcher involved in launching joint research projects with universities and research institutions and supporting the establishment of research institutes.
▼ 16:00-17:00 Hall B
.
Can you design effective teams with visibility into organizational networks?
Session Partner: Kansai Electric Power Co.
As more and more tasks are automated due to the penetration of AI and robots, the way of working required of human beings will center on "co-creation," in which people create new value in cooperation with others. In such an environment, "teamwork" will be emphasized more than ever, and it will be necessary to design effective teams to produce results. Teams composed with a focus on individual skills and knowledge are not necessarily optimal. Good teamwork demonstrates synergistic value beyond the addition of individual talents. In this session, we will discuss how effective teams can be designed by visualizing organizational networks based on the characteristics and relationships among members.
<Speakers
Technical Research Laboratory, Research and Development Office, Kansai Electric Power Co.
Deputy Chief Researcher, Office of Fundamental Technology
Shin Goto
After completing his graduate studies in Open Environmental Science at Keio University, he joined Kansai Electric Power Co. After engaging in planning work for thermal power plants, he was transferred to the Research and Development Office. In the R&D Office, he was in charge of planning new business creation and experienced entrepreneurial activities at KEPCO in 2018. Currently, he is engaged in planning for new business creation, etc. at the Technical Research Institute.
Representative Director, Business Research Lab, Inc.
Mr. Yosuke Date
Representative Director of Business Research Lab, Inc. He holds a Master's degree in Business Administration from Kobe University Graduate School of Business Administration. Master's degree in Business Administration. While enrolled in the same graduate school, he founded LLP Business Research Lab in 2009 and Business Research Lab Inc. in 2011. Since then, he has been developing his research business with a focus on the human resource field.
President and Representative Director, Emosta Inc.
Shuhei Ogawa Mr. (National Guard)
Graduated from Indiana University, USA. Started his own business after 7 years of working at an investment bank. Founded Emosta Inc. in 2017 after hitting it off with his brother-in-law, Xander, a psychologist; engaged in various projects with companies using their self-developed emotion recognition AI with the goal of social implementation of psychological findings through the use of AI.
General Manager, Human Resource Development Division, Liverness, Inc.
Takashi Okazaki
D. in Chemistry, Graduate School of Science, Osaka University. D. in Chemistry from the Graduate School of Science, Osaka University, Japan.
▼ 17:00-17:30 Hall A
<Closing Ceremony
Regional Development Business Department, Osaka Head Office, Liverness Co.
Sho Nakaejima
D., University of the Ryukyus, 2016. D. in Science. D. in Science from the University of the Ryukyus in 2016. He is also involved in the operation of the Regional Tech Planter, which aims to create an ecosystem for industry creation by discovering and fostering local researchers and ventures, and working with government, financial institutions, and local companies.
We are accepting a wide range of poster abstracts, not limited to conference themes. We welcome submissions from academia, companies, school teachers, junior high and high school students, and others in a wide variety of fields and positions.
| Poster Room (3F) | |
| 9:00-9:10 | |
| 9:10-9:30 | Poster Exhibition |
| 9:30-9:50 | |
| 10:00-11:00 | |
| 11:00-12:00 | |
| 12:00-13:00 | break |
| 13:00-14:00 | Poster Exhibition |
| 14:00-15:00 | Poster Core Time |
| 15:00-16:00 | Poster Exhibition |
| 16:00-17:00 | |
| 17:00-17:30 | |
| 17:30 | End |
＜Poster Presentation
| No. | Poster Presentation Title | identity | belong to |
| P-1 | Development of genome-editing therapeutics using oligonucleic acids | Naoyuki Masuda | Nexuspiral Corporation |
| P-2 | Considerations on how to search for diabetic apps | Satoshi Taniguchi | The University of Tokushima |
| P-3 | Legal Issues for Health Tech Products - Online Medical Treatment, Medical AI, Wearable Devices, and Personal Information | Yuhei Shimada | The University of Tokyo |
| P-4 | Dynamic Shape Change of the Dorsal Foot during Walking - Toward the Construction of a Measurement System | Seiji Saito | Okayama Prefectural University |
| P-5 | What we have learned from "barefoot" research | Jun Kaneko | Chukyo University |
| P-6 | Practice of Law Education in Training Childcare Providers: Active Learning for Motivation (2) | Keita Koseki | Yasu Gakuen University |
| P-7 | Cross-sectional survey of play park users and operators - Questionnaire development process | Keita Koseki | Yasu Gakuen University |
| P-8 | Proactive Activities to Promote Active Reading - Through the BiblioBattle Exchange | Tomoya Tsukahara | School Corporation Osaka Meisei Gakuen |
| P-9 | Diversity - How to develop innovators | Anna Shimafuji | Osaka University Graduate School |
| P-10 | Disaster as an Opportunity to Consider "Why Do Research? | Yasuhiro Miki | International Research Institute of Disaster Science, Tohoku University |
| P-11 | Favorite research and stability (money and time) should not be two choices. Challenges of an active postdoctoral researcher engaged in protein research | Keisuke Kaminiwa | Kyoto University |
| P-12 | Are anti-thrombogenic vegetable and fruit varieties effective in preventing thrombotic deaths associated with coronary pneumonia patients? -Collaborative efforts among universities, companies, and farmers can save lives⁉ | Junichiro Yamamoto | Kobe Gakuin University |
| P-13 | Quality control mechanism of the cell's energy factory "mitochondria". | Shohki Kishida | Osaka University Graduate School |
| P-14 | Report on Research and Development of Aerial Wind Power | Daiki Endo | One World Japan (Habataki-do) |
| P-15 | Repair and bonding of carbon fiber reinforced thermoplastics (CFRTP) utilizing resin welding | Masato Kanazaki | Okayama Prefectural University |
| P-16 | Weak pulsed light brings out the potential of plants. | Hiroshi Kajiyama | Faculty of Science and Technology, Tokushima Bunri University |
| P-17 | Investigation of Hypertension Suppression Effect by Manuka Honey | Jilan Sadjawijit Manirat | Kanagawa Prefectural Chuo Agricultural High School |
| P-18 | Taxonomic Study of the Japanese Monotremes of the Genus Kogatatsuchimushi | Yusuke Kamio | Miki Gakuen Hakuryo Junior & Senior High School |
| P-19 | Development of cardiovascular OCT that requires no blood removal, is highly accurate, and safer (Medical revolution by ultra-sensitive OCT capable of deep observation) | Hiroshi Ogawa | Koudai Corporation |
| P-20 | Investigation of the principle of antibacterial and bactericidal properties expressed by nanostructures and efforts toward their application | Ken Ito | Kansai University |
| P-21 | Effects of MMSE in Robot Therapy for Alzheimer's Disease and its Relationship to Cerebral Blood Flow | Naoki Sonoda | Momoyama Gakuin Junior High School |
| P-22 | Hydrogen production from NaCl solution using cation exchange membrane method | Naoki Sonoda | Momoyama Gakuin Junior High School |
| P-23 | Creating Terrabiology and Terrabiotechnology | Masahiko Imashimizu | National Institute of Advanced Industrial Science and Technology (AIST) |
| P-24 | Development of a low-cost and highly efficient microbial production system for homo-γ-polyglutamic acid | Junya Yamamoto | Kobe University Graduate School |
| P-25 | Cardiomyocyte production method using human iPS cells from very low cell density | Mika Takahi | Nagaoka University of Technology |
<Booth Exhibit
| No. | Company Name | About Us |
| B-1 | Kobe Urban Promotion Service | In December 2020, we will open a new open laboratory, Startup Creative Lab (SLC), in Kobe Medical Industry Development Project! We aim to build a "place" for pre- and post-startup ventures to accelerate their R&D and business in Kobe, where research institutes, companies, and hospitals are concentrated. |
| B-2 | MiCAN Technologies, Inc. | In order to contribute to the health of the world, we are engaged in the business of providing blood cells for infectious disease research and other purposes using regenerative medicine technology. Last year, we started providing iPS cell-derived immature dendritic cells (iMylc cells), our first product. |
| B-3 | Cuol Corporation | We have the technology to create humanized mice, mice with human cells and tissues. By creating humanized mice for various diseases, we are working to support the development of novel therapies. |
| B-4 | AMI Corporation | We are developing a "super stethoscope," a stethoscope that assists in the diagnosis of cardiac diseases. We are also implementing "Cloud Kenshin," a core technology of "remote auscultation video chat system" that realizes high quality telemedicine We will realize rapid medical innovation through AI x telemedicine. |
| B-5 | Soilook Corporation | Soilook's management philosophy is "to change the way we see the world and contribute to future security and safety through superior technology and product development." Soilook develops inspection equipment and systems that will become the new eyes of humanity, visualizing components such as leaking gases in the atmosphere to help improve the efficiency of social infrastructure maintenance and management. |
| B-6 | Eve Care Co. | We aim to realize a well-being society filled with kind eyes through mental and physical assessment and care. To this end, we are working on services to assess mental health through hair and to forlow up individuals through training sessions. |
| B-7 | Teclico Corporation | Provide state-of-the-art rehabilitation to realize a society that extends healthy life expectancy. MR/VR rehabilitation that will also lead to solutions to medical/welfare staffing shortages. We aim to provide fun rehabilitation without forgetting entertainment. |
| B-8 | Kihata Keiki Seisakusho Co. | A specialized manufacturer of pressure gauges. Also manufactures and sells respiratory muscle strength measuring devices for medical equipment. With the support of the Kobe Medical Industry Development Organization for healthcare equipment development, the company plans to conduct joint research with Hyogo University of Medical Science on standard values of respiratory muscle strength for modern Japanese people. |
| B-9 | Scrier Corporation | We provide apps, IOMT, medical devices with visible treatment effects, and rehabilitation devices that benefit both dentists and patients by reducing the burden of visits to the dentist (contact opportunities) and making medical information visible. / We enable stable data collection in the oral region, sleep training, not sleep learning. |
| B-10 | Galderia Corporation | We will utilize the high survival ability of the sulfuric acidic hot spring red alga Galderia under high temperature and strong acidity and its ability to selectively adsorb precious metals to achieve culture and CO2 fixation under extreme conditions, while realizing a precious metal recycling flow with a low environmental impact. |
| B-11 | Parity Innovations, Inc. | By applying the airborne image display technology developed by our company and realizing non-contact UI such as airborne switches and airborne touch displays with excellent cleanliness and antifouling properties, we will contribute to the improvement of public health in the age of with corona, namely, countermeasures against infectious diseases. |
| B-12 | Sumitomo Heavy Industries, Ltd. | At Sumitomo Heavy Industries, our goal is to realize a society in which people can work with greater peace of mind. We are taking on the challenge of automating the manufacturing of large structures, which until now required manual labor, through the use of our unique mobile robot technology. |
| B-13 | MicroBiophactory, Inc. | We are developing technologies to produce chemicals using synthetic biology technology. Synthetic biology technology makes it possible to produce substances that could not be produced biologically before. By utilizing this technology, we will manufacture products that aim to eliminate the use of petroleum. |
| B-14 | BioProject, Inc. | Practical Application of Antiviral Microorganisms - Nonspecific Virus Control Effectiveness - This soil bacterium strain, Pseudomonas MS-1, has shown control effectiveness across different species, including coronaviruses and influenza viruses. |
| B-15 | Kawano Lab | Based on the results of our research at Osaka University, we have applied particle analysis technology using magnetic and electric fields to quantify the wettability and dispersibility of particles, monitor the activity state of cells, and evaluate how they are incorporated into capsule materials. |
| B-16 | Beyond Science | Ketobiotic powders can only be hydrolyzed by enzymes in gut bacteria. Ketone bodies are produced in the intestinal bacteria, and the new technology of prokaryotic cell activation transforms the microbiome and activates Tregs. We aim to put this technology to practical use in pet therapy diets. |
| B-17 | Wako Denken Corporation | We are a company that has been designing and developing eco-friendly products based on the electronic circuit business for half a century, but we are also engaged in the medical-related business, manufacturing and selling self-treatment remedies. Please give us a try. |
| B-18 | BeCellBar, LLC | We are developing transdermal absorption methods with the aim of creating a "barrier-free human body. Our goal is to realize a society where people can maintain their health and live a bright life by commercializing vaccines, medicines, and health ingredients that have been difficult to obtain until now. |
| B-19 | arrowroot farm | I am a tomato farmer. Soil preparation is hard work. I cultivate various vegetables in soil made of fiber now. I have acquired cultivation know-how over the past 12 years. I would like to offer this soil to plant factories, aiming at continuous cropping, reduced pesticide use, and cultivation of large vegetables. |
| B-20 | Agri-Shot Corporation | Quantifying the physiological state of plant moisture using a sap flow sensor. This is the first plant physiology sensing system for general farmers in Japan that measures the physiological state of water in a citrus tree under actual cultivation conditions, something that has rarely been investigated until now. |
| B-21 | aiwell Corporation | As a Tokyo Tech venture, we aim to create a future-oriented health management society that enables people to stay healthy by using our comprehensive protein analysis technology, "AI Proteomics," to understand the present and future of all living organisms and to utilize it for health management. |
| B-22 | Saidin Corporation | We aim to create innovative drug development and DDS technology using cyclodextrins, which are cyclic oligosaccharides. |
| B-23 | Student Independent Research Initiative for the Promotion of Science (SINAPS) | By supporting independent research by students who have a high awareness of research, we are expanding the base of research activities. Research presentations: Our main activities are to hold Jamboree and support activities at Science Incarceration, a research presentation event sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT). |
| B-24 | Nariko Seimitsu Co. | We specialize in metal cutting and processing of prototypes and palm-sized products, and can be entrusted with everything from CAD/CAM to lathe, MC, each processing, and surface treatment. We are a group of engineers who give shape to the ideas of developers and ventures. |
| B-25 | MACHICOCO | MACHICOCO SCHOOL" is a school where you can learn about manufacturing onsite from engineers at a local factory. We are preparing a serious course for those who want to learn serious techniques, a petit technique course for those who want to experience and learn in a light way, and a factory experience tour. We are also preparing web-based courses and web-based experience tours for those who are too far away to come. |
| B-26 | Sudix Biotech, Inc. | We have proprietary nano-biotechnological technology that utilizes sugar chains. We are using this technology to develop highly sensitive rapid genetic testing methods for viruses and therapeutic methods targeting cancer cells. |
| B-27 | Humanome Research Institute, Inc. | New lifestyles are required these days. Since before Corona, the institute has been tackling the grand question of "What is a person?" with the aim of creating a healthy society by analyzing big data generated from the latest technology using newly developed artificial intelligence technology. |
| B-28 | Agro Design Studio, Inc. | We are an agrochemical venture aiming to provide safe and secure food. We are engaged in research and development of molecularly targeted agrochemicals by utilizing our knowledge of structural biology. |
English 
Japanese